Cardiovascular risk assessment and treatment in systemic lupus erythematosus

With improved treatment modalities and survival rates, patients with systemic lupus erythematosus live longer and their co-morbidities have become more apparent. Of great concern is cardiovascular disease, which has become a leading cause of death. Lupus patients prematurely develop atherosclerosis,...

Full description

Saved in:
Bibliographic Details
Published inBest practice & research. Clinical rheumatology Vol. 23; no. 4; pp. 481 - 494
Main Authors Elliott, Jennifer R., MD, Manzi, Susan, MD, MPH
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.08.2009
Subjects
Online AccessGet full text

Cover

Loading…